Cargando…

High Phenobarbital Clearance During Continuous Renal Replacement Therapy: A Case Report and Pharmacokinetic Analysis

Phenobarbital is an old antiepileptic drug used in severe epilepsy. Despite this, little is written about the need for dose adjustments in renal replacement therapy. Most sources recommend a moderately increased dose guided by therapeutic drug monitoring. A 14 year old boy with nonketotic hyperglyci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosenborg, Staffan, Saraste, Lars, Wide, Katarina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602450/ https://www.ncbi.nlm.nih.gov/pubmed/25101986 http://dx.doi.org/10.1097/MD.0000000000000046

Ejemplares similares

Pharmacokinetics and dialytic clearance of apixaban during in vitro continuous renal replacement therapy
por: Andrews, Lauren, et al.
Publicado: (2021)

Clearance of micronutrients during continuous renal replacement therapy
por: Lumlertgul, Nuttha, et al.
Publicado: (2020)

Pharmacokinetics and Optimal Dosing of Phenobarbital
por: Shareef, Safiullah, et al.
Publicado: (2018)

Clearance of meropenem during continuous renal replacement therapy in critically ill patients
por: Thalhammer, F, et al.
Publicado: (1999)

Imipenem/Relebactam Ex Vivo Clearance during Continuous Renal Replacement Therapy
por: Jang, Soo Min, et al.
Publicado: (2021)

Tedizolid clearance by in vitro continuous renal replacement therapy model
por: Lewis, SJ, et al.
Publicado: (2015)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy
por: Wenzler, Eric, et al.
Publicado: (2021)

Correction to: Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy
por: Wenzler, Eric, et al.
Publicado: (2022)

Pharmacokinetics of Intravenous and Oral Phenobarbital Sodium in Healthy Goats
por: Yates, Liana M., et al.
Publicado: (2020)

Pharmacokinetics of ciprofloxacin during continuous renal replacement therapy in intensive care patients – new assessment
por: Onichimowski, Dariusz, et al.
Publicado: (2020)

Pharmacokinetics of meropenem in intensive care patients receiving continuous renal replacement therapy
por: Giles, LJ, et al.
Publicado: (1998)

Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy
por: Xu, Xiaoying, et al.
Publicado: (2016)

Neutrophil gelatinase-associated lipocalin clearance during veno-venous continuous renal replacement therapy in critically ill patients
por: de Geus, Hilde R. H., et al.
Publicado: (2010)

Adsorption and Clearance of the Novel Fluorescent Tracer Agent MB-102 During Continuous Renal Replacement Therapy: In Vitro Results
por: Jang, Soo M., et al.
Publicado: (2023)

2526. Ex Vivo Assessment of Sulbactam-Durlobactam (SUL-DUR) Clearance during Continuous Renal Replacement Therapy (CRRT)
por: Abouelhassan, Yasmeen, et al.
Publicado: (2023)

Flucytosine Pharmacokinetics in a Critically Ill Patient Receiving Continuous Renal Replacement Therapy
por: Kunka, Megan E., et al.
Publicado: (2015)

Effects of continuous renal replacement therapy on linezolid pharmacokinetic/pharmacodynamics: a systematic review
por: Villa, Gianluca, et al.
Publicado: (2016)

Effect of Chronic Administration of Phenobarbital, or Bromide, on Pharmacokinetics of Levetiracetam in Dogs with Epilepsy
por: Muñana, K.R., et al.
Publicado: (2015)

What Is the Best Predictor of Phenobarbital Pharmacokinetics to Use for Initial Dosing in Neonates?
por: Šíma, Martin, et al.
Publicado: (2021)

Transdermal Detection of MB-102 and Correlation to Meropenem Pharmacokinetics During Continuous Renal Replacement Therapy: In Vivo Results
por: Dorshow, Richard B., et al.
Publicado: (2023)

Treatment with echinocandins during continuous renal replacement therapy
por: González de Molina, Francisco Javier, et al.
Publicado: (2014)

Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study
por: Broeker, A., et al.
Publicado: (2018)

Mesalazine as a cause of fetal anemia and hydrops fetalis: A case report
por: Ek, Sverker, et al.
Publicado: (2017)

Case Report: Therapeutic Drug Monitoring of Polymyxin B During Continuous Renal Replacement Therapy in Two Pediatric Patients: Do Not Underestimate Extracorporeal Clearance
por: Xu, Caifang, et al.
Publicado: (2022)

Heparin algorithm for anticoagulation during continuous renal replacement therapy
por: Ostermann, Marlies, et al.
Publicado: (2010)

Adsorption and caspofungin dosing during continuous renal replacement therapy
por: Honore, Patrick M., et al.
Publicado: (2019)

Management for Electrolytes Disturbances during Continuous Renal Replacement Therapy
por: Baeg, Song In, et al.
Publicado: (2022)

Population Pharmacokinetics and Dosing Optimization of Gentamicin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
por: He, Sha, et al.
Publicado: (2022)

Renal replacement therapy does have impact on beta-lactam clearance
por: Yu, Zhenwei
Publicado: (2023)

Protein losses in continuous renal replacement therapies
por: Rodigues, MG, et al.
Publicado: (2005)

Clarifications on Continuous Renal Replacement Therapy and Hemodynamics
por: Wang, Xiao-Ting, et al.
Publicado: (2017)

Continuous Renal Replacement Therapy in Preterm Infants
por: Noh, Eu Seon, et al.
Publicado: (2019)

Basics of continuous renal replacement therapy in pediatrics
por: John, Jacob C., et al.
Publicado: (2019)

High Anion Gap Metabolic Acidosis on Continuous Renal Replacement Therapy
por: Sriperumbuduri, Sriram, et al.
Publicado: (2020)

Protein losses and nitrogen balance during continuous renal replacement therapy
por: Hayami, H, et al.
Publicado: (2011)

β-lactam antibiotic concentrations during continuous renal replacement therapy
por: Beumier, Marjorie, et al.
Publicado: (2014)

Metabolic disturbances encountered during pediatric continuous renal replacement therapy
por: Soysal, D, et al.
Publicado: (2006)

Dialysis disequilibrium syndrome occurring during continuous renal replacement therapy
por: Tuchman, Shamir, et al.
Publicado: (2013)

Successful management of severe hyponatraemia during continuous renal replacement therapy
por: Vassallo, Diana, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_joa8oa1d2gi72ei1uc37ngj22p